Have you been diagnosed with non-small cell lung cancer? Have you already been treated with an anti PDL-1 therapy and chemotherapy? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of the investigational drug RMC-6236 to docetaxel.

We are looking for adults ages 18 and up who are interested in using digital tools, a smartphone app, and text messages to help them make positive changes in their eating, activity, and weight.

We're exploring how students use AI tools, like ChatGPT, to help with schoolwork and how colleges are responding. We want to know how these tools help students, especially those that are first in their family to attend college, in subjects like science and math. We'll collect information from schools on the kinds of rules they are putting in place. This way, we can understand better how AI is helping students and how colleges can support everyone fairly.

We are doing a new study to better understand the experiences and beliefs of parents with daughters who have or had early puberty .

We are interested in talking to people with chronic non-cancer pain about their experiences of receiving treatment in the UNC Health System, especially times that they felt particularly empowered or disempowered. Participation includes one focus group lasting 60 to 90 minutes.

In this study, we want to find out what makes people decide to buy things in a convenience store.

We're looking at two alcohol sensors you can wear, the BACtrack Skyn and ArborSense. We want to know how easy and comfortable these are for you to use every day. Your feedback will help us decide which device is better for future studies.

Have you been diagnosed with Leukemia? Do you have a functioning kidney, liver, and cardiac organ? If so, you may be able to participate in a study on a new drug called Ziftomenib. We want to find out if it hooking their interest enough to click on the link to is safe for people with Leukemia. Compensation provided.

We want you to help us understand an important part of people's lives in the United States: how they think about who they are. We need your help to make our questions clearer. Your feedback will help us create better surveys for everyone. If you join the study, you will look at some draft questions and tell us what you think.

The purpose of this study is an initial pilot study to develop the safety, feasibility, and tolerability of a new type of individualized transcranial alternating current stimulation (tACS) to treat antenatal depression, which delivers personalized stimulation waveforms based individual participant EEG activity. In the previous stage of the study, we investigated this intervention in healthy controls. In the current phase of this study, we are investigating this intervention in people with antenatal depression (depression during pregnancy).